EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Identification of a novel EphB4 inhibitor, Sanguinarine, which attenuates β-catenin signaling to inhibit tumor proliferation and migration in lung cancer

Asmat Ullah, Chuanzan Zhou, Wang Xiao, Haroon Iqbal, Facai Zhang, Peng Nan, Naveed Ullah Khan, Dechao Feng, Yefu Liu, Ran Tao

Journal of Advanced Research · 2026-11 · 89 · 1077-1092

DOI: 10.1016/j.jare.2026.02.044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Advanced Research, 2026-11. Verfasst von Asmat Ullah und 9 weiteren Autor:innen. Beteiligte Einrichtung: General Surgery, Cancer Center, Department of Hepatobiliary & Pancreatic Surgery and Minimally Invasive Surgery, Zhejiang Provincial People's Hospita…. Hauptthemen laut MEDLINE: Lung Neoplasms, Receptor, EphB4, Benzophenanthridines, Isoquinolines. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Medical Science and Technology Project of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsReceptor, EphB4BenzophenanthridinesIsoquinolinesbeta CateninHumansCell ProliferationCell MovementAnimalsMiceCell Line, TumorMice, NudeFemaleXenograft Model Antitumor AssaysSignal Transduction

Stichwörter der Autor:innen

EMTEphrin type-B receptor 4Lung cancerMigration and MetastasisSanguinarine

Substanzen

Receptor, EphB4BenzophenanthridinessanguinarineIsoquinolinesbeta CateninEPHB4 protein, human

Autor:innen und Institutionen

  • General Surgery, Cancer Center, Department of Hepatobiliary & Pancreatic Surgery and Minimally Invasive Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou 31…
  • Urology & Nephrology Center, Department of Urology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou 310014, Zhejiang, China.
  • Eye Hospital, School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou 325027, Zhejiang, China.
  • College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310012, China.
  • Urology & Nephrology Center, Department of Urology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou 310014, Zhejiang, China; Division of Surgery & Interventional S…
  • Department of Hepatopancreatobiliary Surgery, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning 110042, China.

Förderung

  • Medical Science and Technology Project of Zhejiang Province

Zitieren

APA

Ullah, A., Zhou, C., Xiao, W., Iqbal, H., Zhang, F., Nan, P., Khan, N. U., Feng, D., Liu, Y., & Tao, R. (2026). Identification of a novel EphB4 inhibitor, Sanguinarine, which attenuates β-catenin signaling to inhibit tumor proliferation and migration in lung cancer. Journal of Advanced Research, 89, 1077-1092. https://doi.org/10.1016/j.jare.2026.02.044

Vancouver

Ullah A, Zhou C, Xiao W, Iqbal H, Zhang F, Nan P, et al. Identification of a novel EphB4 inhibitor, Sanguinarine, which attenuates β-catenin signaling to inhibit tumor proliferation and migration in lung cancer. Journal of Advanced Research. 2026;89:1077-1092. doi:10.1016/j.jare.2026.02.044

BibTeX
@article{Ullah2026,
  author = {Ullah, Asmat and Zhou, Chuanzan and Xiao, Wang and Iqbal, Haroon and Zhang, Facai and Nan, Peng and Khan, Naveed Ullah and Feng, Dechao and Liu, Yefu and Tao, Ran},
  title = {Identification of a novel EphB4 inhibitor, Sanguinarine, which attenuates β-catenin signaling to inhibit tumor proliferation and migration in lung cancer},
  journal = {Journal of Advanced Research},
  year = {2026},
  volume = {89},
  pages = {1077--1092},
  doi = {10.1016/j.jare.2026.02.044}
}
Kostenlos starten →